Commercialization Council

Michael Brenner, MD

Michael Brenner, MD, is the Chief of the Division of Rheumatology, Immunology, Allergy at Brigham and Women’s Hospital and the Theodore B. Bayles Professor of Medicine at Harvard Medical School. Dr. Brenner holds an undergraduate degree from Washington University and a medical degree from Vanderbilt University School of Medicine.

The Brenner laboratory has made a number of significant discoveries in the fields of antigen presentation and autoimmune diseases such as rheumatoid arthritis. Their discoveries in the biology of adhesion molecules in rheumatoid arthritis have defined key mechanisms in inflammatory arthritis, including the important role of mast cells; identified cadherins in synovial fibroblasts and their critical role in synovial lining development and joint pathology in rheumatoid arthritis; and established an in vitro organ culture system to study synoviocyte functions and invasive characteristics.

Prior to joining Brigham and Women’s Hospital, Dr. Brenner held research positions at the Dana Farber Cancer Institute and the University of California, Los Angeles. He is a member of the National Academy of Sciences.

Back to Commercialization Council